Viewing Study NCT05809505


Ignite Creation Date: 2025-12-25 @ 3:29 AM
Ignite Modification Date: 2025-12-26 @ 2:10 AM
Study NCT ID: NCT05809505
Status: UNKNOWN
Last Update Posted: 2023-06-07
First Post: 2023-03-09
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Feasibility and Safety of the 360-degree Turn Test Delivered Via Telehealth
Sponsor:
Organization:

Raw JSON

{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'D009103', 'term': 'Multiple Sclerosis'}], 'ancestors': [{'id': 'D020278', 'term': 'Demyelinating Autoimmune Diseases, CNS'}, {'id': 'D020274', 'term': 'Autoimmune Diseases of the Nervous System'}, {'id': 'D009422', 'term': 'Nervous System Diseases'}, {'id': 'D003711', 'term': 'Demyelinating Diseases'}, {'id': 'D001327', 'term': 'Autoimmune Diseases'}, {'id': 'D007154', 'term': 'Immune System Diseases'}]}}, 'protocolSection': {'designModule': {'phases': ['NA'], 'studyType': 'INTERVENTIONAL', 'designInfo': {'allocation': 'NA', 'maskingInfo': {'masking': 'NONE', 'maskingDescription': 'The researchers who evaluate the results and make statistics will be blinded.'}, 'primaryPurpose': 'DIAGNOSTIC', 'interventionModel': 'SINGLE_GROUP', 'interventionModelDescription': 'The 360-degree turn test will be applied to patients first in the hospital environment and then by teleconference method, and the results will be recorded.'}, 'enrollmentInfo': {'type': 'ESTIMATED', 'count': 50}}, 'statusModule': {'overallStatus': 'UNKNOWN', 'lastKnownStatus': 'RECRUITING', 'startDateStruct': {'date': '2023-05-01', 'type': 'ACTUAL'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2023-06', 'completionDateStruct': {'date': '2025-01-01', 'type': 'ESTIMATED'}, 'lastUpdateSubmitDate': '2023-06-05', 'studyFirstSubmitDate': '2023-03-09', 'studyFirstSubmitQcDate': '2023-04-09', 'lastUpdatePostDateStruct': {'date': '2023-06-07', 'type': 'ACTUAL'}, 'studyFirstPostDateStruct': {'date': '2023-04-12', 'type': 'ACTUAL'}, 'primaryCompletionDateStruct': {'date': '2024-12-01', 'type': 'ESTIMATED'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'Number of patients who safely completed the 360-degree turn test and completed the measurement in a way that could be used in clinical trials or follow-up', 'timeFrame': '1 day', 'description': 'Feasibility and safety of the 360-degree turn test delivered via telehealth will be measured by the percived safety from researchers and results of the tests obtained from procedure.'}]}, 'oversightModule': {'oversightHasDmc': False, 'isFdaRegulatedDrug': False, 'isFdaRegulatedDevice': False}, 'conditionsModule': {'keywords': ['telehealth', 'multiple sclerosis', '360-degree Turn Test'], 'conditions': ['Multiple Sclerosis']}, 'descriptionModule': {'briefSummary': 'Walking, balance problems and falls are common in patients with multiple sclerosis. The 360-degree turn test is a test used to evaluate balance. Telerehabilitation is a rehabilitation system that has been increasingly used in recent years. Still, there is a need for studies on whether there is any difference between face-to-face evaluations with patients and telehealth methods. This study aims to investigate the feasibility and safety of the 360-degree turn test delivered via telehealth.', 'detailedDescription': "The 360-degree turn test will be performed in the participant's home environment using a standardized protocol from previously published literature. Exercise professionals will administer the test during a single videoconferencing exercise appointment. Prior to the study commencement, clinicians will be given a 30-minute education session and written protocol to facilitate the standardized and safe performance of the test.\n\nThe test will be performed in the participant's home environment using videoconferencing. The clinician will explain the 360-degree turn test. Clinicians will record the device used by the participant. Where possible, participants will be instructed to adjust their device or camera to improve clinician visibility. The test will be stopped immediately if the participant reports increased pain, a moderate-significant increase in breathlessness, or is unsteady."}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['ADULT', 'OLDER_ADULT'], 'maximumAge': '90 Years', 'minimumAge': '18 Years', 'healthyVolunteers': False, 'eligibilityCriteria': 'Inclusion Criteria:\n\n* Clinical diagnosis of multiple sclerosis\n* EDSS score ≤ 5.5\n\nExclusion Criteria:\n\n* Not giving consent\n* History of dislocation or surgery in the lower limbs\n* History of fall within six months\n* Any other disease, medication or intervention that can cause balance disturbance\n* Patients who cannot use devices that is required for teleconference\n* Patients that cannot understand English/ Turkish'}, 'identificationModule': {'nctId': 'NCT05809505', 'briefTitle': 'Feasibility and Safety of the 360-degree Turn Test Delivered Via Telehealth', 'organization': {'class': 'OTHER_GOV', 'fullName': 'Uskudar State Hospital'}, 'officialTitle': 'Feasibility and Safety of the 360-degree Turn Test Delivered Via Telehealth', 'orgStudyIdInfo': {'id': '360 Degree 1'}}, 'armsInterventionsModule': {'armGroups': [{'type': 'EXPERIMENTAL', 'label': 'Multiple Sclerosis Patients', 'description': 'Patients with a diagnosis of multiple sclerosis.', 'interventionNames': ['Diagnostic Test: 360-degree Turn Test', 'Other: Expanded Disability Status Scale', 'Other: Perceived Exertion']}], 'interventions': [{'name': '360-degree Turn Test', 'type': 'DIAGNOSTIC_TEST', 'description': 'The 360-degree turn test is a measure of dynamic balance. The person tested turns in a complete circle (360 degrees) while the time to complete and/or the number of steps to complete the turn is recorded.', 'armGroupLabels': ['Multiple Sclerosis Patients']}, {'name': 'Expanded Disability Status Scale', 'type': 'OTHER', 'description': 'The Expanded Disability Status Scale (EDSS) is a method of quantifying disability in multiple sclerosis and monitoring changes in the level of disability over time. It is widely used in clinical trials and in the assessment of people with multiple sclerosis. The EDSS scale ranges from 0 to 10 in 0.5 unit increments that represent higher levels of disability.', 'armGroupLabels': ['Multiple Sclerosis Patients']}, {'name': 'Perceived Exertion', 'type': 'OTHER', 'otherNames': ['Borg Scale'], 'description': 'The Borg Rating of Perceived Exertion (RPE) is a way of measuring physical activity intensity level. Perceived exertion is how hard you feel like your body is working. It is based on the physical sensations a person experiences during physical activity, including increased heart rate, increased respiration or breathing rate, increased sweating, and muscle fatigue. Although this is a subjective measure, your exertion rating based on a 6 to 20 rating scale, may provide a fairly good estimate of your actual heart rate during physical activity.', 'armGroupLabels': ['Multiple Sclerosis Patients']}]}, 'contactsLocationsModule': {'locations': [{'zip': '34000', 'city': 'Istanbul', 'state': 'Başakşehir', 'status': 'RECRUITING', 'country': 'Turkey (Türkiye)', 'contacts': [{'name': 'Fatih Bağcıer, Assoc. Prof.', 'role': 'CONTACT'}, {'name': 'Fatih Bağcıer, Assoc. Prof.', 'role': 'SUB_INVESTIGATOR'}], 'facility': 'Başakşehir Çam ve Sakura City Hospital', 'geoPoint': {'lat': 41.01384, 'lon': 28.94966}}], 'centralContacts': [{'name': 'Mustafa H Temel, M.D.', 'role': 'CONTACT', 'email': 'mhuseyintemel@gmail.com', 'phone': '+905342714872'}, {'name': 'Fatih Bağcıer, M.D.', 'role': 'CONTACT', 'email': 'bagcier_42@hotmail.com', 'phone': '+905442429042'}], 'overallOfficials': [{'name': 'Mustafa H Temel, M.D.', 'role': 'PRINCIPAL_INVESTIGATOR', 'affiliation': 'Uskudar State Hospital'}]}, 'ipdSharingStatementModule': {'infoTypes': ['STUDY_PROTOCOL', 'SAP'], 'timeFrame': 'One year', 'ipdSharing': 'YES', 'description': 'Individual participant data will be shared upon reasonable request by the co-author.', 'accessCriteria': 'Individual participant data will be shared upon reasonable request by the co-author.'}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Uskudar State Hospital', 'class': 'OTHER_GOV'}, 'responsibleParty': {'type': 'PRINCIPAL_INVESTIGATOR', 'investigatorTitle': 'Principal Investigator', 'investigatorFullName': 'Mustafa Hüseyin Temel', 'investigatorAffiliation': 'Uskudar State Hospital'}}}}